These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5595092)

  • 21. Tetanus toxoid vs. tetanus antitoxin.
    Frazier CA
    N C Med J; 1992 Sep; 53(9):445. PubMed ID: 1407021
    [No Abstract]   [Full Text] [Related]  

  • 22. [Behavior of tetanus antitoxin level in human serum following simultaneous prevention with tetanus immunoglobulin].
    Harrfeldt HP
    Langenbecks Arch Chir; 1969; 325():947-9. PubMed ID: 4190268
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the importance of qualitative indexes of tetanus anatoxin in the effectiveness of this product for human vaccination].
    Esrig M; Armaşu V
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):401-6. PubMed ID: 5877478
    [No Abstract]   [Full Text] [Related]  

  • 24. [Several properties of low-molecular weight tetanus antitoxin].
    Aleksevich IaI; Kryzhanovskiĭ GN
    Biull Eksp Biol Med; 1976 Mar; 81(3):331-3. PubMed ID: 953282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Duration of immunity after administration of heterologous and homologous tetanus antitoxin and its enzymatical disintegration (author's transl)].
    Krasemann C; Schneider W
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jan; 143(1):59-75. PubMed ID: 4282907
    [No Abstract]   [Full Text] [Related]  

  • 26. Excessive use of tetanus toxoid boosters.
    Edsall G; Elliott MW; Peebles TC; Eldred MC
    JAMA; 1967 Oct; 202(1):111-3. PubMed ID: 6071998
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [On the behavior of free amino acids in plasma following vaccination with Tetanus vaccine].
    Stöckl W; Stacher A; Weiser M; Zacherl MK; Müller H
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Dec; 134(3):276-86. PubMed ID: 4232910
    [No Abstract]   [Full Text] [Related]  

  • 29. [Behavior of antitetanus toxin in rabbits, following injection of tetanus antitoxin, injection of anatoxin or injection of antitoxin and anatoxin].
    Guasco C
    G Mal Infett Parassit; 1967 Jul; 19(7):423-8. PubMed ID: 5606369
    [No Abstract]   [Full Text] [Related]  

  • 30. [The duration of passive immunity in the prevention of tetanus].
    Matveev KI; Kashintseva NS; Petrov PN; Kasparova EM; Khramova SA; Popova KhA
    Zh Mikrobiol Epidemiol Immunobiol; 1970 May; 47(5):32-6. PubMed ID: 5455481
    [No Abstract]   [Full Text] [Related]  

  • 31. Duration of maternally derived immunity to tetanus and response in newborn foals given tetanus antitoxin.
    Liu IK; Brown SL; Kuo J; Neeley DP; Feeley JC
    Am J Vet Res; 1982 Nov; 43(11):2019-22. PubMed ID: 7181201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Preparation and evaluation of antitetanus human immunoglobulins. 1. Selection of plasma donors with high tetanus antibody level].
    Klenowska Z; Daszyński J; Galazka A; Sporzyńska Z
    Med Dosw Mikrobiol; 1976; 28(3):243-8. PubMed ID: 1004061
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental study upon the efficacy of some accelerated vaccination schedules in tetanus prophylaxis.
    Dimache G; Croitoru M; Durbaca S; Stoean C; Dimache A
    Roum Arch Microbiol Immunol; 1993; 52(4):247-54. PubMed ID: 7827361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunity to tetanus among the 25 to 30-year-old population].
    Simonsen O; Kjeldsen K; Møller-Madsen B; Nørgaard A; Simonsen L; Heron I
    Ugeskr Laeger; 1984 Apr; 146(18):1341-4. PubMed ID: 6495408
    [No Abstract]   [Full Text] [Related]  

  • 35. Determination of tetanus antitoxin in the sera of children of Owsley County, Kentucky: a community survey of immunity by serologic methods.
    Meira AR; Ildirim I; Furcolow ML
    Am J Public Health Nations Health; 1970 Aug; 60(8):1439-41. PubMed ID: 5465456
    [No Abstract]   [Full Text] [Related]  

  • 36. Human antitoxin in prophylaxis and treatment of tetanus.
    Med Lett Drugs Ther; 1965 Feb; 7(4):13-4. PubMed ID: 5831349
    [No Abstract]   [Full Text] [Related]  

  • 37. [More recent viewpoints on tetanus prevention].
    Lehnert S
    Dtsch Zahnarztl Z; 1969 Apr; 24(4):267-71. PubMed ID: 5252378
    [No Abstract]   [Full Text] [Related]  

  • 38. Attenuated immune response to tetanus toxoid in young healthy men protected against tetanus.
    Danilova E; Shiryayev A; Kristoffersen EK; Sjursen H
    Vaccine; 2005 Oct; 23(42):4980-3. PubMed ID: 15985319
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The status of maternally acquired tetanus immunity in newborn infants].
    Pietsch M; Schütt KH
    Gesundheitswesen; 1993 Jul; 55(7):364-6. PubMed ID: 8369604
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.
    Tafaghodi M; Sajadi Tabassi SA; Jaafari MR
    Int J Pharm; 2006 Aug; 319(1-2):37-43. PubMed ID: 16701972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.